{
    "Trade/Device Name(s)": [
        "Simplexa\u2122 Group A Strep Direct",
        "Simplexa\u2122 Group A Strep Positive Control Pack"
    ],
    "Submitter Information": "Focus Diagnostics, Inc.",
    "510(k) Number": "K143651",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133883"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PGX",
        "OOI"
    ],
    "Summary Letter Date": "December 22, 2014",
    "Summary Letter Received Date": "December 23, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.2680"
    ],
    "Regulation Name(s)": [
        "Streptococcus spp. nucleic acid-based assay"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "virology"
    ],
    "Analyte(s)": [
        "Group A Streptococcus (Streptococcus pyogenes) DNA"
    ],
    "Specimen Type(s)": [
        "Throat swab"
    ],
    "Specimen Container(s)": [
        "Swab"
    ],
    "Instrument(s)/Platform(s)": [
        "3M Integrated Cycler"
    ],
    "Method(s)/Technology(ies)": [
        "Real-time PCR",
        "Qualitative nucleic acid amplification"
    ],
    "Methodologies": [
        "PCR-based detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Simplexa\u2122 Group A Strep Direct real-time PCR assay and positive control pack for qualitative detection of Group A Streptococcus DNA from throat swabs.",
    "Indications for Use Summary": "Aid in the diagnosis of Group A Streptococcus infection in human patients with pharyngitis symptoms using throat swabs in laboratory settings; control pack intended for use with the assay.",
    "fda_folder": "Microbiology"
}